DAVA Pharmaceuticals Counterpart to Registration Rights Agreement for 7.25% Senior Notes Due 2022

Contract Categories: Business Finance › Registration Rights Agreements
Summary

DAVA Pharmaceuticals, Inc. agrees to become a Guarantor under the Registration Rights Agreement dated May 6, 2014, related to the 7.25% Senior Notes due 2022. By signing this counterpart, DAVA is bound by all terms of the original agreement, which involves Endo Finance LLC, Endo Finco Inc., RBC Capital Markets, LLC, and Deutsche Bank Securities Inc. This ensures DAVA's obligations as a guarantor for the registration of the notes, as required by the agreement.

Read More Arrow
EX-10.201 7 ex10201-rracounterpartre72.htm AUG RRA ###-###-#### Ex. 10.201 - RRA Counterpart re 7 25% Notes due 2022 (DAVA Guarantee)
Exhibit 10.201

EXECUTION VERSION

Counterpart to Registration Rights Agreement
August 11, 2014
The undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated May 6, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, RBC Capital Markets, LLC and Deutsche Bank Securities Inc., relating to the 7.25% Senior Notes due 2022, to be bound by the terms and provisions of such Registration Rights Agreement.



Exhibit 10.201

IN WITNESS WHEREOF, the undersigned has executed this counterpart as of the date first written above.
DAVA PHARMACEUTICALS, INC.
By:
/s/ Deanna Voss
Name:
Deanna Voss
Title:
Assistant Secretary


[Signature to Registration Rights Agreement Counterpart - 7.25% Senior Notes due 2022]